Half of Atopic Dermatitis Patients Left Prescriptions Unfilled
A 2026 report found that despite a formal diagnosis, many patients with eczema do not access prescribed treatments.
Updated on Oct. 1, 2026 in Allergies
Live Poll
Is your medical insurance plan providing enough support for managing chronic skin conditions?
According to the August 2026 State of Atopic Dermatitis report, half of all insured patients with diagnosed eczema failed to fill their related prescriptions. This gap in care persists even as advanced practice providers increasingly manage the majority of clinic visits for the condition in the United States.
Why it matters
The high rate of unfilled prescriptions suggests significant barriers to treatment adherence or access for those managing atopic dermatitis. Identifying these gaps is crucial, especially as patients face varied access to specialized care depending on their state's practitioner density.
The State of Atopic Dermatitis report analyzed claims and service data from the United States, finding that 50% of insured patients with the condition do not fill their related prescriptions. The analysis also noted that advanced practice providers deliver 42% to 60% of all dermatitis-related visits.
The players
Milliman
An international actuarial and consulting firm that provides healthcare analysis and data reports.
Joint Task Force
A collaborative body that establishes clinical guidelines for the management of allergic and dermatologic conditions.
The details
Advanced practice providers, such as nurse practitioners and physician assistants, play a significant role in managing atopic dermatitis, particularly in rural areas where specialist availability is limited. Their participation is vital, as clinical guidelines updated in 2023 discourage the use of systemic corticosteroids due to the risk of rebound flares and side effects, favoring more targeted therapies like dupilumab or other specialized immunomodulators.
Timeline
2023: The Joint Task Force published updated clinical guidelines for atopic dermatitis.
August 2026: Milliman published the State of Atopic Dermatitis report.
October 1, 2026: An article regarding treatment trends was published.
Health Landscape
This report evaluates how patient care for atopic dermatitis aligns with the 2023 Joint Task Force guidelines. It underscores a persistent gap between standard treatment recommendations and real-world medication adherence.
If you have a diagnosis of atopic dermatitis and find it difficult to manage your prescriptions or treatment plan, discuss these challenges during your next visit. Whether you see a physician or an advanced practice provider, it is important to confirm that your current regimen aligns with the latest clinical standards.
The takeaway
The gap between clinical guidelines and prescription fulfillment highlights a need for better patient engagement in eczema treatment plans. If you are struggling with flare-ups or medication access, ask your provider about non-steroidal treatment alternatives and potential support resources.
Further reading
Learn more about managing skin sensitivities in our Allergies section.
More information
View the full findings and data on The State of Atopic Dermatitis report.
Source note: This article includes information reported by Ajmc.
Live Poll
Is your medical insurance plan providing enough support for managing chronic skin conditions?
